PIK3CD and chronic myelogenous leukemia, BCR-ABL1 positive: In 1995, p210 bcr-abl was shown to interact with the p85 subunit of PI3K thereby increasing PI3K activity substantially in a model for chronic myelogenous leukemia [38].